Skip to Main Content

Allogene Therapeutics, the new and buzzy CAR-T cancer therapy startup backed by former Kite Pharma CEO Arie Belldegrun, is recruiting veteran Cowen biotech analyst Eric Schmidt to become its new chief financial officer, STAT has learned.

Schmidt confirmed to STAT that he is considering a job offer with Allogene but “no decision has been made” on whether he will accept. Schmidt says he informed his higher-ups at Cowen last week that he was considering a move.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!